Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.

Back

EHRA Premium Access

Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.

Session: Rapid Fire 4: The shocking truth of device therapy

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor A. Quast (Amsterdam, NL)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))

0 follower

9 more presentations in this session

Refining ICD decision-making in non-ischaemic patients in the post-DANISH era: analysis from a nationwide database of daily remote-monitoring transmissions in a real-world cohort

Speaker: Doctor G. Forleo (Milano, IT)

Long-term performance of contemporary internal cardioverter defibrillator leads: a single center experience

Speaker: Doctor R. Brenner (St. Gallen, CH)

Incidence of appropriate therapy and mortality after ICD generator replacement: results from a real-world nationwide prospective cohort

Speaker: Doctor M. Ruwald (Hellerup, DK)

Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system

Speaker: Professor S. Schmidt Pedersen (Odense, DK)

Predictors of acute effectiveness of subcutaneous implantable cardioverter-defibrillator according to the implantation technique

Speaker: Doctor P. Francia (Rome, IT)

Access

Abstract

Access the full session

Rapid Fire 4: The shocking truth of device therapy

Speakers: Doctor A. Quast, Doctor G. Forleo, Doctor R. Brenner, Doctor M. Ruwald, Professor S. Schmidt Pedersen...

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources